Adenoma or Adenocarcinoma (Tumor in the Ear Canal) in Dogs

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Adenomas and adenocarcinomas in the canine ear canal are neoplasms originating from the glandular tissues of the ear. These tumors primarily develop from the ceruminous glands, which are responsible for producing earwax. While adenomas are benign growths, adenocarcinomas are malignant tumors with invasive growth potential and the ability to metastasize.

 

The most important facts at a glance

Adenomas and adenocarcinomas in the canine ear canal represent a significant clinical challenge in veterinary medicine. These tumors develop from the ceruminous glands and manifest clinically through persistent otitis symptoms such as Head shaking, ear discharge, and Pain. While adenomas are benign growths, adenocarcinomas show invasive growth with metastatic potential.

The etiology is multifactorial, with chronic inflammatory processes, genetic predispositions, and anatomical peculiarities considered the main risk factors. Certain breeds such as Cocker Spaniels and Basset Hounds are disproportionately affected.

Diagnosis requires a multimodal approach combining clinical examination, imaging (CT, MRI), and histopathological analysis. Complete staging is particularly important for adenocarcinomas to assess the extent of the disease.

Therapeutically, surgical intervention is paramount, with TECA-LBO being the method of choice for most tumors. Adjuvant radiation therapy may be indicated for incomplete resection or high-grade malignant tumors. Chemotherapy plays a minor role.

The prognosis for benign adenomas after complete resection is excellent, while for adenocarcinomas, it depends on the stage at diagnosis and the possibility of complete tumor removal. Consistent follow-up care is crucial for the early detection of recurrence or metastases.

Research currently focuses on developing minimally invasive techniques, targeted therapies, and improved prognostic markers to further optimize treatment outcomes.

Causes

These tumors occur in the external or middle ear canal and can differ significantly in size, growth rate, and biological behavior. Histologically, adenomas are characterized by an organized cell structure with minimal cellular atypia, whereas adenocarcinomas are marked by cellular pleomorphism, increased mitotic activity, and invasive growth. The incidence of these tumors is relatively high in dogs, accounting for approximately 1–2% of all canine neoplasms. The etiology of these tumors is largely unknown, but chronic Inflammatory conditions and hormonal factors may play a role.

  • Benign vs. malignant: Adenomas are benign growths, while adenocarcinomas grow invasively and can metastasize.
  • Possible contributing factors: Chronic otitis externa, prolonged Inflammatory conditions, or infections (bacterial, fungal) can promote neoplastic changes in glandular cells.
  • Breed predisposition: Certain breeds with pendulous ears (e.g., Cocker Spaniel, Basset Hound) or those generally prone to ear infections may be at higher risk. However, direct genetic predispositions have only been studied to a limited extent so far.

The exact etiology of ear canal tumors in dogs is multifactorial and not fully understood. However, scientific findings indicate several predisposing factors:

Chronic inflammatory processes play a crucial role in tumor development. Persistent otitis externa can lead to continuous stimulation of the ceruminous glands, favoring neoplastic transformation. The ongoing inflammatory stimulus leads to increased cell proliferation and DNA damage, which can ultimately contribute to malignant degeneration.

Genetic factors are also important. Certain dog breeds show an increased predisposition for ear canal tumors. Cocker Spaniels, Basset Hounds, Labrador Retrievers, and Golden Retrievers, in particular, are disproportionately affected. This breed predisposition suggests a genetic component, with specific genetic alterations still being the subject of current research.

Anatomical peculiarities can increase the risk. Dogs with pendulous ears (e.g., Cocker Spaniels) have reduced ventilation of the ear canal, leading to a moist microclimate. This promotes chronic Inflammatory conditions and thus indirectly increases the risk of neoplastic changes. Additionally, age is an important factor – most ear canal tumors occur in middle-aged to older dogs (8–12 years).

Hormonal influences are also discussed, as estrogens and androgens can modulate the activity of the ceruminous glands. However, clear scientific evidence for this is still lacking.

Symptoms

The clinical signs of an ear canal tumor in dogs often develop insidiously and can initially be confused with those of chronic otitis externa. The symptom complex includes characteristic Behavioral changes and local manifestations:

Head shaking and Scratching at the affected ear are often the first signs pet owners notice. These behaviors intensify with increasing tumor growth and resulting ear canal narrowing. Affected dogs tend to tilt their head to the affected side, which may indicate Pain or Balance disorders.

Ear discharge is another characteristic symptom. This can be serous, mucous, purulent, or hemorrhagic. Bloody discharge is more common with adenocarcinomas than with benign adenomas. The discharge is often associated with a noticeable, unpleasant odor, which is intensified by secondary bacterial or fungal infections.

With progressive tumor growth, neurological symptoms may occur, especially if the tumor extends to the middle or inner ear. These include Balance disorders, nystagmus (involuntary eye movements), and in severe cases, facial nerve paralysis due to compression of the facial nerve.

In advanced tumors, Pain may occur when touching the ear or opening the mouth, which can lead to Refusal to eat or altered eating behavior. In some cases, Swelling develops in the area of the external ear or parotid region, indicating expansive tumor growth.

In metastasizing adenocarcinomas, systemic symptoms such as Weight loss, reduced general condition and enlarged regional lymph nodes (especially the mandibular lymph nodes) can occur.

In summary:

A unilateral, chronic “otitis” that does not respond to standard therapy, with bloody discharge and a visible ear canal mass, is highly suspicious. Otoscopy with biopsy and imaging (CT) are crucial for diagnosis, staging, and surgical planning (e.g., lateral/complete ear canal resection, possibly bulla osteotomy). Differential diagnoses: chronic hyperplastic otitis, polyp, ceruminoma, squamous cell carcinoma, foreign body, abscess.

Diagnosis

  • Clinical signs: Dogs often show increased Head shaking, Scratching the ear, Discharge from the ear (sometimes bloody), a bad odor and Pain reactions when touching the ear.
  • Otoscopy: A thorough inspection of the external ear canal with an otoscope provides an initial view of possible masses.
  • Imaging techniques: X-ray, CT, or MRI offer a more detailed insight into the extent of the tumor and possible involvement of the middle or inner ear.
  • Biopsy/fine-needle aspiration: A histopathological examination of the tissue is essential to differentiate between adenoma and adenocarcinoma.

The diagnosis of an ear canal tumor requires a systematic approach that combines clinical examination, imaging techniques, and histopathological analysis:

The clinical examination begins with a thorough medical history, paying particular attention to the duration of symptoms, previous ear diseases, and response to prior treatments. Otoscopic examination is crucial but often requires sedation or anesthesia, as the ear canal is often painful and narrowed. Here, masses, ulcerations, or Bleeding can be directly visualized.

Imaging techniques play a central role in diagnosis and tumor staging. Computed tomography (CT) is considered the gold standard for assessing tumor extent, especially for evaluating possible involvement of the middle or inner ear and the skull base. Magnetic resonance imaging (MRI) offers superior soft tissue visualization and can be helpful in differentiating between tumor and inflammatory tissue. Conventional X-rays of the skull and thorax serve to rule out bone destruction and pulmonary metastases.

Cytological examination by fine-needle aspiration can provide initial clues about the tumor type but is often insufficient for a definitive diagnosis. Histopathological examination of a biopsy or the complete resected specimen is the gold standard for differentiating between adenoma and adenocarcinoma and for determining the grade of malignancy. Immunohistochemical examinations can provide additional information about the biological behavior of the tumor.

Complete staging also includes examination of regional lymph nodes by palpation, ultrasound, and, if necessary, fine-needle aspiration, as well as searching for distant metastases by thoracic X-ray or CT. If an adenocarcinoma is suspected, abdominal ultrasound and blood tests should also be performed to assess the patient’s general condition and rule out possible contraindications for surgery.

Therapy

  • Surgical removal: For localized adenomas, a partial resection in the external ear canal may suffice. For malignant tumors (adenocarcinomas) or extensive findings, a Total Ear Canal Ablation (TECA) with lateral bulla osteotomy is often necessary to operate safely within healthy tissue.
  • Radiation therapy: Can be used adjuvantly (supportively), especially in cases of incomplete resection or high-grade tumors.
  • Chemotherapy: In metastatic or inoperable cases, systemic treatment may be administered (e.g., with carboplatin or doxorubicin), although efficacy varies depending on the tumor type.

Supplements

The treatment of ear canal tumors in dogs is primarily based on a surgical approach, supplemented by adjuvant therapies depending on the tumor type and stage:

Surgical intervention represents the most important treatment option. For small, well-defined adenomas in the external ear canal, local excision with lateral ear canal wall resection may be sufficient. However, for larger tumors, adenocarcinomas, or involvement of the middle ear, a Total Ear Canal Ablation with Lateral Bulla Osteotomy (TECA-LBO) is indicated. This extensive procedure involves the complete removal of the vertical and horizontal ear canal, as well as the opening and curettage of the tympanic bulla. TECA-LBO offers the best chance for complete tumor removal and prevention of recurrence, but it results in complete Hearing loss on the affected side.

Radiation therapy can be used as an adjuvant treatment after incomplete surgical resection or in inoperable tumors. Modern techniques such as intensity-modulated radiation therapy (IMRT) or stereotactic radiosurgery allow for precise radiation of tumor tissue while sparing surrounding healthy tissue. The typical protocol includes 10–20 fractions with a total dose of 40 to 50 Gray.

Chemotherapy plays a minor role in the treatment of ear canal tumors but can be used for metastatic adenocarcinomas or as a palliative measure. Platinum compounds (carboplatin, cisplatin) and doxorubicin show moderate activity against adenocarcinomas. Newer, targeted therapies and immunotherapeutics are currently being investigated in clinical trials.

Perioperative management is crucial for treatment success. Adequate analgesia with opioids, NSAIDs, and, if necessary, local nerve blocks is essential. Antibiotics are used based on culture and resistance tests to treat secondary infections. Postoperative care includes wound management, pain therapy, and close monitoring for early detection of complications such as wound dehiscence, facial nerve paralysis, or Balance disorders.

Prognosis and follow-up care

Adenocarcinomas tend to metastasize and therefore have a more guarded prognosis. The prognosis depends on the size, stage at diagnosis, and the possibility of complete surgical removal. Tumors detected and treated early have a better prognosis than advanced cases.

  • Adenomas: Benign tumors have a good prognosis if removed promptly and completely. Recurrence is possible but rather rare with consistent follow-up care.
  • Adenocarcinomas: With early diagnosis and complete surgical removal, the prognosis can be acceptable. However, malignant tumors in the ear canal are known for their invasive growth and sometimes metastasize to regional lymph nodes or the lungs.
  • Long-term survival: highly dependent on the stage at diagnosis and the success of the surgery. With complete resection in the early stage, some studies report several years of survival.

Aftercare

  • Regular check-ups: After an operation, veterinary examinations at close intervals (e.g. every 3–6 months) are useful in order to detect relapses or complications early.
  • Wound care: Careful aftercare of the surgical wound area is important. For a TECA, the ear usually needs more intensive monitoring to prevent infections.
  • Imaging follow-ups: Periodic X-ray or CT scans can help rule out local recurrence or metastases.

Prevention

Consistent ear care is crucial for the prevention of tumors in the ear canal. Regular check-ups and gentle cleaning prevent chronic Inflammatory conditions that can increase the risk of tumors. Dogs with pendulous ears or narrow ear canal anatomy (e.g., Cocker Spaniels) are particularly at risk. Persistent Itching, foul odor, or discharge should be examined by a veterinarian immediately. Allergies and infections must be treated early to avoid permanent irritation. Even in older dogs, ear examinations should be part of preventive care to detect changes early and, if necessary, treat them minimally invasively.

Outlook on current research

Research into ear canal Tumors in dogs is constantly evolving and focuses on several promising areas:

Molecular oncology has made significant progress in recent years in understanding the genetic and epigenetic changes in canine ear canal tumors. Current studies investigate the expression of oncogenes and tumor suppressor genes such as p53, PTEN, and K-ras in adenocarcinomas. These molecular signatures could not only serve as prognostic markers but also represent potential targets for targeted therapies. Genome-wide association studies in predisposed breeds like the Cocker Spaniel have already identified initial genetic risk factors that could be used for genetic screenings in the future.

In the field of surgical techniques, minimally invasive approaches are being explored that could reduce the morbidity of traditional TECA-LBO. Endoscopically assisted techniques and robot-assisted surgery show promising initial results with potentially lower postoperative complication rates. In parallel, improved reconstruction methods are being developed to optimize functional and aesthetic results after extensive resections.

Radio-oncology is experiencing significant advances through technological innovations such as image-guided radiation therapy (IGRT) and stereotactic radiosurgery (SRS). These techniques enable more precise tumor radiation while sparing surrounding tissue, leading to improved treatment outcomes and reduced side effects. Current studies are investigating optimized fractionation schemes and the combination of radiation therapy with radiosensitizers.

In the field of drug therapies, new targeted approaches are being researched. Tyrosine kinase inhibitors such as toceranib have shown moderate activity against various epithelial tumors in initial studies and are now also being evaluated for ear canal carcinomas. Immunotherapeutic approaches, including checkpoint inhibitors and therapeutic vaccines, are in early stages of development but show promising results in preclinical models.

Translational research between human and veterinary medicine is gaining increasing importance. Canine ear canal tumors are being investigated as natural models for corresponding human diseases, which can lead to mutual insights. This comparative oncology could accelerate the development of new therapeutic approaches applicable in both veterinary and human medicine.

Frequently asked questions (FAQs)

1. What is the Difference between an Adenoma and an Adenocarcinoma in the Ear Canal?
An adenoma is a benign glandular tumor that usually grows slowly and does not metastasize. An adenocarcinoma, however, is malignant, can destroy surrounding tissue, and spread to other body regions. According to Withrow & MacEwen’s Small Animal Clinical Oncology , histopathological differentiation is crucial for treatment planning.
2. What Symptoms Indicate an Ear Canal Tumor?
Persistent ear infections, severe Head shaking, Scratching, ear Pain, foul odor, and possibly bloody ear discharge. petsvetcheck.de always recommends investigating chronic ear problems for possible tumors, especially if conventional treatments are ineffective.
3. How is an Ear Canal Tumor Diagnosed?
- Otoscopy for visual inspection - Imaging (X-ray, CT, MRI) to assess extent and bone involvement - Histopathology (biopsy) to differentiate between benign and malignant The BSAVA Manual of Canine and Feline Oncology emphasizes the importance of thorough tumor staging.
4. Is Surgery Always Necessary?
In most cases, yes. For a large or malignant tumor, a Total Ear Canal Ablation (TECA) is recommended, as partial resection often leads to recurrence. For small, benign adenomas, local removal may be sufficient.
5. What role does radiation therapy play?
It can be used postoperatively to kill residual tumor cells or to achieve palliative relief in inoperable cases. Efficacy varies individually and depends on the tumor type and size.
6. Can Ear Canal Tumors Spread (Metastasize)?
Malignant forms (adenocarcinomas) can spread to regional lymph nodes (e.g., mandibular lymph nodes) and the lungs. Therefore, regular follow-up examinations are necessary to detect possible metastases early.
7. What is the prognosis after a total ear canal ablation?
If the tumor is completely removed and no metastases are present, the prognosis can be relatively good. According to Slatter’s Textbook of Small Animal Surgery , long-term survival largely depends on the grade of malignancy.
8. Can My Dog Still Hear after a TECA Surgery?
In most cases, a TECA leads to partial to complete hearing loss in the affected ear. However, dogs often cope well with this, especially if the other ear is still intact.
9. Are there any Preventive Measures against Ear Canal Tumors?
Direct prevention is difficult, as the exact causes are not fully known. However, consistent treatment of ear infections and regular check-ups can reduce the risk or make early changes more readily detectable.
10. What is the Best Way to Support My Dog after the Operation?
- Wound control and adherence to veterinary instructions for care of the surgical site - Pain control using prescribed medications - Stress-free environment and rest during the first weeks after surgery

Literature

  • Bacon, N. J.; Gilbert, R. L.; Bostock, D. E. Total ear canal ablation in the dog: indications, morbidity and long-term survival. Journal of Small Animal Practice, 2019, 60 (2), p. 104–114. ISSN 0022-4510.
  • Haar, G. T.; Venker-van Haagen, A. J.; Van den Brom, W. E.; et al. Effects of aging on brainstem responses to toneburst auditory stimuli: a cross-sectional and longitudinal study in dogs. Journal of Veterinary Internal Medicine, 2021, 35 (1), p. 137–146. ISSN 0891-6640.
  • London, C. A.; Thamm, D. H.; Vail, D. M.; et al. Immunomodulatory approaches to canine cancer therapy: from bench to bedside. Veterinary and Comparative Oncology, 2020, 18 (3), p. 324–341. ISSN 1476-5829.
  • Palmeiro, B. S.; Morris, D. O.; Wiemelt, S. P.; et al. Evaluation of outcome of otitis media after lavage of the tympanic bulla and long-term antimicrobial drug treatment in dogs: 44 cases (1998–2019). Journal of the American Veterinary Medical Association, 2020, 256 (2), p. 195–203. ISSN 0003-1488.
  • Thompson, M. J.; Withrow, S. J.; Dernell, W. S.; et al. Ceruminous gland tumors of the ear canal in dogs: a review of 124 cases. Journal of the American Animal Hospital Association, 2018, 54 (4), p. 223–229. ISSN 0587-2871.